KB
Kurt W Briner
Director

Kurt W Briner insider trades: BioAmber (BIOA) stock buys and sales

Director, BioAmber Last trade Nov 8, 2016 30 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2011
3
Companies
last trade 2016

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kurt reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 8, 2016BIOA↑ Buy$38K
May 24, 2016BIOA↑ Buy$4K
May 23, 2016BIOA↑ Buy$76K
Aug 6, 2015BIOA↑ Buy$239K
May 6, 2015BIOA↑ Buy$90K
Nov 10, 2014BIOA↑ Buy$140K
Sep 9, 2014BIOA↑ Buy$60K
Aug 25, 2014BIOA↑ Buy$164K
Aug 12, 2014BIOA↑ Buy$2K
Aug 11, 2014BIOA↑ Buy$34K
Nov 14, 2013BIOA↑ Buy$50K
Aug 15, 2013BIOA↑ Buy$71K
Feb 3, 2012PGNX↓ Sell$337K
May 16, 2011PGNX↓ Sell$165K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BIOA insiders

Open-market trades in the last 12 months

About Kurt W Briner's insider trades

Kurt W Briner is a director at BioAmber (BIOA). Since May 16, 2011, Kurt has reported 12 open-market purchases worth $969K and 2 sales worth $502K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.